Public-health topic
Published Research Radar records connected to the Antimicrobial resistance topic through the auditable classification pipeline.
Evidence stream
30 of 82 publications shown
ACS Medicinal Chemistry Letters
Why it matters nowThe findings address antimicrobial resistance and limited treatment options for latent tuberculosis infection, which affects approximately 90% of infected individuals. The hypoxia-activated prodrug approach may improve treatment of persistent tuberculosis within hypoxic niches that drive prolonged treatment regimens.
Veterinary Research
Why it matters nowThe authors frame the combination of pathogenicity, multidrug resistance, and horizontal gene transfer potential via ICEs and prophages as a serious public health risk from healthy pig-derived S. suis, calling for enhanced surveillance.
Wellcome Open Research
Why it matters nowThe compilation frames melioidosis as an escalating yet frequently ignored infectious threat that demands improved monitoring frameworks, uniform testing standards, and interdisciplinary coordination to decrease adverse health outcomes.
BMC Infectious Diseases
Why it matters nowThe findings are positioned to inform antibiotic stewardship and hospital infection control by highlighting temporal shifts in K. pneumoniae epidemiology and resistance patterns around the pandemic transition.
Artificial Intelligence in Gastroenterology
Why it matters nowImproving detection accuracy for abdominal tuberculosis in resource-constrained environments could mitigate diagnostic delays and support more standardized care delivery pathways.
Diagnostics
Why it matters nowIncorporating these genomic methodologies into standard care pathways may strengthen disease control efforts and optimize therapeutic decision-making, particularly in underserved regions.
Microbial Genomics
Why it matters nowResults inform public health interventions by clarifying transmission dynamics and antimicrobial resistance patterns relevant to treatment strategies. The authors emphasize the necessity for enhanced national and cross-border genomic surveillance to manage control efforts effectively.
Pharmaceutical Journal
Why it matters nowAssessing these treatment metrics addresses documented concerns regarding therapeutic failure, mortality risks, and potential antimicrobial resistance development.
Tuberculosis and socially significant diseases
Why it matters nowThe findings highlight that advanced genitourinary tuberculosis is common and strongly associated with disseminated respiratory disease, drug resistance, and HIV-negative status, which may inform screening and treatment protocols.
PLOS Neglected Tropical Diseases
Why it matters nowRegional incidence estimates and strain distributions offer foundational parameters for evaluating pediatric immunization strategies and directing sanitation resource allocation.
International Journal of Infectious Diseases
Why it matters nowThe widespread presence of resistant strains and genetic diversity suggests that local infection control strategies and laboratory testing protocols may require updates to address emerging transmission patterns.
Vaccine
Why it matters nowThe study provides an assay method for evaluating functional antibody responses during development of Shigella vaccines. The abstract places this work in the context of shigellosis burden and antimicrobial-resistance concerns, but it does not report clinical effectiveness, disease reduction, or population-level outcomes.
Microbiology spectrum
Why it matters nowThe identification of synergistic metabolic vulnerabilities provides a foundation for developing combination treatments aimed at overcoming antimicrobial resistance in tuberculosis infections.
The Lancet Infectious Diseases
Why it matters nowThe abstract frames sexually transmissible shigellosis as a public health concern requiring interventions beyond traditional enteric-disease measures. It also highlights antimicrobial stewardship as relevant across pathogens in a syndemic setting.
BMC Infectious Diseases
Why it matters nowThe reported trends underscore requirements for enhanced diagnostic capacity, coordinated immunization efforts, and tighter medication regulation to manage worsening respiratory disease loads.
Microbiology spectrum
Why it matters nowDocumenting this rare tuberculosis complex variant in a captive species highlights the necessity for refined diagnostic protocols and precise antimicrobial testing. The authors propose that coordinated monitoring of affected wildlife facilities and associated personnel may help limit potential cross-species spread.
Global Journal of Medical and Pharmaceutical Sciences
Why it matters nowThe elevated resistance rates to conventional treatments underscore the importance of enhanced farm biosecurity and prudent antibiotic stewardship to limit resistance accumulation in food animal environments.
Bioorganic & medicinal chemistry
Why it matters nowThe compounds represent potential hit candidates for developing novel antitubercular agents effective against drug-resistant tuberculosis, addressing a critical need for new therapeutic options.
International Journal of Infectious Diseases
Why it matters nowThe convergence of resistance, hypervirulence, and potential vaccine escape within a dominant lineage is framed by the authors as grounds to revisit antibiotic stewardship and pertussis vaccination strategies.
The Lancet Microbe
Why it matters nowAuthors emphasize the necessity of prioritizing systematic monitoring for resistance to maintain effective treatment protocols. Elevated resistance levels in certain subgroups underscore the importance of updated diagnostic and therapeutic approaches.
The Lancet Microbe
Why it matters nowThe authors position APAP and AFC as candidate multidrug combinations intended to address emerging artemisinin-reduced susceptibility in sub-Saharan Africa, warranting further clinical development.
Clinical Infectious Diseases
Why it matters nowShorter treatment regimens that prevent drug resistance development and achieve relapse-free cure would reduce treatment burden and improve tuberculosis control, particularly in high-endemic settings where many proposed monitoring tools are suitable.
Clinical Infectious Diseases
Why it matters nowThese projections inform strategic planning for managing resistance risks associated with upcoming therapeutic approvals for sexually transmitted infections.
PLoS neglected tropical diseases
Why it matters nowThe findings demonstrate that syndromic cholera diagnosis can miss diverse diarrheal etiologies. Mobile metagenomic sequencing may improve etiological resolution and outbreak response in resource-limited settings where diagnostic capacity is constrained.
Pulmonology
Why it matters nowThe abstract frames diagnostic delay as relevant to tuberculosis control in Portugal, particularly for underserved populations. It links reducing delays with preventable morbidity, ongoing transmission, health inequities, and progress toward TB targets.
BMC Infectious Diseases
Why it matters nowThe findings provide genomic context for XDR-TB resistance-associated variation in the studied Argentine isolates. The authors state that the results support continued research and surveillance efforts, but the abstract does not quantify population-level effects or clinical outcomes.
BMC Infectious Diseases
Why it matters nowThe findings indicate geographic variation in H. influenzae antimicrobial resistance and differences associated with beta-lactamase production. The authors state that these results support reliable susceptibility testing and resistance-containment efforts, while the abstract reports caution regarding clarithromycin in settings with high resistance.
BMC Infectious Diseases
Why it matters nowThe findings highlight the critical public health challenge posed by emerging antibiotic resistance in gonococcal infections and emphasize the need for antimicrobial stewardship, enhanced contact tracing, and comprehensive monitoring systems.
The Lancet Microbe
Why it matters nowThe work supports development of a controlled human infection model that could accelerate novel gonorrhoea prevention and therapeutic strategies, addressing a pathogen of major public health concern due to rising prevalence and antimicrobial resistance. The selection approach prioritizes participant safety and identifies strains relevant for evaluating current and future vaccines.
Journal of global antimicrobial resistance
Why it matters nowThe findings indicate that some resistance-associated mutations or deletions identified in this sample may not be detected by routine diagnostic methods described by the authors. The abstract also states that known resistance mutations could be assessed using Xpert MTB/XDR together with Xpert MTB/RIF, while rapid methods for detecting resistance to newer drugs remain needed.
